This is an Open clinical trial to study the safety and efficacy of Chandrakanthi Choornam in 40 patients with Oligospermia. Chandrakanthi choornam is a formulation consisting of 25 ingredients. They are Curculigo orchioides -rhizome, Madhuca longifolia - flower, Cinnamomum verum -bark,Cinnamomum tamala-Leaf, Syzygium aromaticum - flower bud,Coscinium fenestratum-stem bark,Mesua ferrea-flower, Maerua arenaria-tuber, Adhatoda vasica- seed, Moringa oleifera-seed, Lawsonia inermis-seed, Vitis vinifera- fruit, Bombax ceiba- gum, Bambusa aurundinaceae-salt,Phoenix dactilifera- fruit,Ilicium verum- flower, Mucuna prurita-seed, Cyperus rotundus- rhizome, Glycyrrhiza glabra-root, Tribulus terrestris-fruit, Cuminum cyminum-seed,Costus speciosus-root,Myrsitica fragrans-seed, Alternanthera sessilis-seed and asphaltum-mineral. Treatment duration is three months.Study is conducted in India (Chennai). Primary outcome measure is to see the changes in sperm count, motility and morphology. Secondary Outcome measure is to see the impact on the harmone level.
METHODOLOGY OF PROPOSED RESEARCH: I. Preclinical study II. Clinical study I. PRECLINICAL STUDY: Standardization Of The Study Drug 1. Botanical Identification 2. Chemical Identification 3. Preparation of the study drugs: Formulation: Chandrakanthi choornam Source : Chikicharathna deepam Part II. Pg-168 (Approved sastric book as per drugs \& cosmetic act 1940. 4. Chemical methods of testing 5. Pharmacological study : A. Spermotogenic Activity 6. Toxicological study : A. Acute Toxicity B. Long term Toxicity II. CLINICAL STUDY Conducted as per the guidelines of GCP accepted by Ayush adapted from the ICH. A. Pilot study B. Main study
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
40
12gm in milk - OD dose; Oral route; 3 Months ( 90days) - duration Preparation from approved sastric book as per drugs \& cosmetic act 1940
National institute of siddha
Chennai, Tamil Nadu, India
Sperm concentration per milliliter of seminal fluid
Changes in the total number of sperm cells per milliliter of seminal fluid were evaluated from baseline to three months
Time frame: 90 days
Proportion of Sperm motility
Changes in the percentage of total and progressive motility of sperm were evaluated from baseline to three months
Time frame: 90 days
Proportion of Sperm morphology
Changes in the percentage of sperm cells with normal forms were evaluated from baseline to three months
Time frame: 90 days
Impact on the hormonal level due to the clinical trial
Changes in serum Testosterone, LH and FSH were estimated from baseline to three months
Time frame: 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.